Introduction
Mitochondria-generated ATP plays important roles in both nuclear and cytoplasmic maturation of oocytes [1] [2] [3] [4] [5] [6] . A study using mice lacking mitochondrial transcription factor A (TFAM) which is essential for the replication, transcription, and maintenance of mitochondrial DNA (mtDNA) has demonstrated that oocytes must contain threshold numbers of mtDNA to support the developmental competence of embryos to grow viable fetuses [7] . The amount of mtDNA copy numbers in whole embryos remained unchanged during successive Electronic supplementary material The online version of this article (doi:10.1007/s10815-017-0886-6) contains supplementary material, which is available to authorized users.
cell divisions in mice [7, 8] leading to a progressive decrease in mtDNA in cleaving blastomeres. In contrast, the mtDNA copy numbers in cattle [9] and pigs [10, 11] have been reported to decrease temporarily during embryo development. Thus, quantitative changes in mitochondria in preimplantation embryos vary among animal species.
The numbers of mtDNA copy in oocytes or embryos have been shown to be involved in causes of infertility (ovarian insufficiency [12] and endometriosis [13] ), mutations of mtDNA [14] , female age [15] , and aneuploidy of embryos [15, 16] . On the other hand, it has been shown that overall levels of mtDNA are largely equal between blastocysts stratified by ploidy, age, or implantation potential [17] . However, the changes in mtDNA copy numbers in human embryos during preimplantation development remain obscure.
In aerobic oxidation, fatty acids and sugars are metabolized using O 2 to CO 2 and H 2 O, and the released energy is converted to the chemical energy of phosphoanhydride bonds in ATP. In animal cells, ATP is generated mainly by this process. Thus, the measurement of oxygen consumption rate (OCR) of developing embryos would be a useful measurement to evaluate their normality and developmental competence. The OCR of mitochondria in mammalian embryos increases toward the blastocyst stage in mice and cattle [18] [19] [20] suggesting that the mitochondrial function also increases during embryogenesis. Once blastulation has occurred, trophectoderm (TE) cells rapidly increase the mtDNA copy numbers to match the energy demands of the cells [19] . Human embryos that consume more oxygen develop to blastocysts more quickly than those that consume less [21] . Blastocysts that consume more oxygen after vitrification also have higher developmental competence [22] . These findings are consistent with the fact that formation of the blastocoel cavity depends on cellular Na/KATPase activity [23] . However, the interactions between mitochondrial functions and mtDNA copy numbers in human embryos during preimplantation development have not been elucidated.
Here, to evaluate mitochondrial function during human embryonal development, we assessed the OCR of human oocytes and embryos during days 2 and 5 in the presence or absence of mitochondrial toxins. The mtDNA copy numbers in each oocyte or embryo were also measured.
Materials and methods

Ethical approval
This study was approved by the local ethics Institutional Review Board of IVF Namba Clinic and the Japan Society of Obstetrics and Gynecology (Registry nos. 135 and 138). Specimens were donated by 71 couples who gave informed consent. Vitrified-warmed pronuclear stage zygotes, cleavage stage embryos on days 2 and 3, and blastocysts on day 5 after insemination by intracytoplasmic sperm injection (ICSI) were used for the study after the couples had given informed consent. Mature oocytes were obtained after additional culture of immature cells donated for research at the time of ICSI 42 h after the administration of hCG. In Japan, the donation of oocytes which are mature 42 h after hCG injection is not generally admitted because of ethical reasons. Thus, in this study, we used oocytes with delayed cell cycle.
Ovarian stimulation and insemination
Patients were subjected to controlled ovarian stimulation according to their medical history as described [24] . For gonadotropin-releasing hormone (GnRH) agonist cycles, patients received oral contraceptive pills (1 mg norethisterone and 0.05 mg mestranol, Aska Pharmaceutical, Co., Ltd., Tokyo, Japan) on day 14 of the previous cycle and continued for 10 days, and a GnRH agonist (600 μg/day, Suprecur® nasal solution 0.15%; Mochida Pharmaceutical, Tokyo) on day 21 of the previous cycle until the induction of ovulation. On day 3 of the cycle, they received doses of follicle stimulating hormone (FSH) ranging from 150 to 300 IU for 4 days followed by administration of urinary human menopausal gonadotropin (hMG) at doses or 150-450 IU until ovulation induction. For GnRH antagonist cycles, a GnRH antagonist (2.5 mg, Ganirelix Acetate, MSD K.K., Tokyo) was administered daily after the leading follicles reached 13-14 mm in diameter as diagnosed by ultrasound. Ovulation was induced by human chorionic gonadotropin (hCG) administration when at least one leading follicle reached 18 mm in diameter. Transvaginal follicle aspiration was carried out 36 h after the hCG injection. Insemination was carried out by ICSI 40 h after hCG administration.
To avoid contamination from mtDNA from spermatozoa attached to the zona pellucida, all embryos in this study were generated by ICSI. Oocytes were collected between July 2004 and November 2014.
OCR
Normally fertilized zygotes were frozen by vitrification [25] at the pronuclear (PN) stage at 16-18 h, or on days 2, 3, and 5 after ICSI. After warming, embryos were cultured at 37°C under 5% CO 2 , 5% O 2 , and 90% N 2 with high humidity in potassium simplex optimized medium containing amino acids [26] and 5% (v/v) synthetic serum substitute (SSS, 99193; Irvine Scientific, St. Ana, CA, USA) for more than 19 h except for day 5 embryos. Day 5 blastocysts were cultured for 8 h and then their OCR was assessed. Embryos that showed cleavage within 19 h before the measurement were considered as developing, and those that did not were regarded as arrested. Blastocysts on day 5 that reached the expanded stage with a tightly packed inner cell mass (ICM) and TE consisting of cohesive epithelium were included in the analysis.
The OCR of samples was measured using scanning electrochemical microscopy (SCEM, CRAS-1.0; Clino Ltd., Miyagi, Japan) as previously described [22] at 37°C under air. Briefly, each oocyte or embryo was transferred into a well filled with 5-mL human tubal fluid (HTF) medium buffered with 21 mM HEPES containing 2.7 mM glucose and 0.33 mM pyruvate (modified HTF medium; Irvine Scientific) containing 5% SSS, where it sank to the bottom of a cone-shaped microwell and remained at the lowest point. A platinum microdisk electrode was loaded with 5 ml of HEPES-buffered medium, and its tip potential was maintained at −0.6 V versus the Ag/AgCl electrode with a potentiostat to monitor the local oxygen concentration. The microelectrode scanned along the z-axis from the edge of the sample, and the OCR was calculated with custom software based on the spherical diffusion theory. OCR was measured at three points for each embryo and at the ICM and two TE sides of blastocysts. The OCR was also measured in the presence of mitochondrial toxins [27] . Stock solutions of 1 mM carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP; C2920, Merck Millipore Co., Darmstadt, Germany) and 1 M sodium cyanide (380970, Merck Millipore Co.) were prepared in ethanol and water, respectively. During the recording of oxygen consumption by embryos in the modified HTF medium, either FCCP or cyanide was added to give final concentrations of 1 μM and 1 mM, respectively. Cyanide at 1 mM completely inhibits mitochondrial cytochrome c oxidase activity. Characteristics of the donated oocytes and embryos are shown in the Supplementary Table. mtDNA All specimens after OCR measurement were sampled in 2 μl DNase-free water individually and cryopreserved at −65°C until assay. Each sample was lysed in 4 μl lysis buffer (20 mM Tris (# 252859, Merck Millipore Co.), 0.4 mg/ml proteinase K (# P2308, Merck Millipore Co.), 0.9% Nonidet P-40 (# 21-3277-2, Merck Millipore Co.), and 0.9% Tween 20 (# P1379, Merck Millipore Co.)) at 55°C for 30 min, followed by heating at 95°C for 5 min; the lysate was diluted in DNasefree water to a final volume of 40 μl. A 4-μl aliquot of the lysate was added to 12.5 μl Quantifact SYBR Green master mix (Qiagen, Venlo, Limburg, the Netherlands), 8.5 μl DNase-free water and 1 μM of each primer (Table 1) . Polymerase chain reaction (PCR) amplifications were run in duplicate in a Rotorgene Q thermal cycler (Qiagen) according to the following conditions: 95°C for 5 min, 40 cycles of 95°C for 5 s, and 60°C for 10 s. SYBR green fluorescence was measured at the end of each cycle. The melting curve was analyzed to check the specificity of the PCR products. A standard curve was generated for each run using tenfold serial dilutions representing copies of the external standard (10 3 to 10 6 copies). The external standard used in the present study was the PCR product of the corresponding gene cloned into a vector using the Zero Blunt TOPO PCR cloning kit (Invitrogen Life Sciences, Carlsbad, CA, USA), and the product was confirmed by sequencing before use.
The primers were designed using Primer3Plus (http:// sourceforge.net/projects/primer3/) and ND6 (525 bp region from 14,149 to 14,673) and ND4 sequences (1,378 bp region from 10,760 to 12,137) of human mitochondria (NC012920.1). To assess the mtDNA deletion [28, 29] , the ratio of copy numbers of ND4 and ND6 regions was calculated. When the ratio was >0.75, the embryo was regarded as not having mtDNA deletions.
To standardize the copy number of mtDNA after DNA amplification, we used an internal genomic control (b-actin) for normalization. Quantitative RT-PCR was performed similarly to mtDNA amplification using 1 μM of each primer (Table 1) . A standard curve was generated for each run using tenfold serial dilutions representing copies of the external standard (1 to 10 3 copies). The copy number of mtDNA per cell was calculated by dividing the mtDNA copy number by the number of blastomeres before compaction or by nuclear number after compaction.
Analysis of cytochrome c oxidase (CCO)
Vitrified specimens were fixed at each stage (4 cells to blastocysts) after more than 24-h culture, and mature oocytes were immediately fixed to measure CCO activity as described [16] . Briefly, they were fixed in 0.05-M phosphate-buffered saline (PBS) with 2% glutaraldehyde (v/v, TAAB Laboratories, Berkshire, UK), 0.15-M sucrose (WAKO, Osaka, Japan), and for 15 min at 4°C. After rinsing in the same buffer, they were incubated in 0.05-M PBS with 1.4-mM 3,3′-diaminobenzidine (DAB) tetrahydrochloride (Merck Millipore Co.), 0.1% (w/v) type II cytochrome c (Merck Millipore Co.), 0.23-M sucrose, and 0.0002% catalase (w/v; Merck Millipore Co.) for 3 h at 37°C. Samples were then washed in PBS for 1 h. They were then postfixed in 1% (v/v) osmium tetroxide (TAAB Laboratories) for 2 h at 4°C. They were dehydrated in increasing concentration of ethanol and embedded in epoxy resin. Ultrathin sections were stained with uranyl acetate and examined using transmission electron microscopy (TEM; JEM-1011, JEOL, Tokyo, Japan). Mitochondria that showed well-developed crista structure and deeply stained membrane were categorized as having high CCO activity (High). Mitochondria with deeply stained membrane and few crista structures were categorized as having moderate CCO activity Mitochondria with poorly stained membranes and few crista structures were categorized as having low CCO activity.
Definitions
Mitochondrial OCR (mtOCR) was calculated by subtracting the value obtained in the presence of cyanide from those obtained without any mitochondrial toxins. The maximum (max mtOCR) was calculated by subtracting the values obtained in the presence of cyanide from those obtained in the presence of FCCP. The OCR/mtDNA was defined as the value of mtOCR divided by mtDNA copy numbers.
Statistics
Data for mtDNA and OCRs were compared by Steel-Dwass following Kruskal-Wallis analysis of variance (ANOVA). Effect of cause of infertility on the number of mtDNA copy was assessed using t test. Data for CCO activity were compared by Cochran-Armitage test among five groups and by Fisher's exact test between two groups. P < 0.01 was considered statistically significant.
Results mtDNA copy numbers
There were no significant differences in maternal age among the groups (Supplementary table) . Deletions of mtDNA were not detected in this study. The number of mtDNA copy per specimen in embryos decreased transiently (P < 0.01; Fig. 1 ) at 2-cell (102,584), 9-14-cell (123,293), and morula stages (115,199) compared with oocyte (215,564). The number of mtDNA copy significantly increased (P < 0.01) on day 5 (expanded blastocyst stage, 410,212) compared with those in oocytes, 2-14-cell and morula stage embryos. Cause of infertility did not affect the number of mtDNA copy in 2-cell stage (P = 0.1549, endometriosis 113,795 vs. unknown (only male factor) 95,857) and in 3-4-cell stage embryos (P = 0.5654, endometriosis 200,702 vs. unknown (only male factor) 119,108).
The numbers of mtDNA copy per cell in embryos decreased gradually (P < 0.01; Fig. 2 ) from oocytes (211,564) toward 2-cell (51,292), 3-4-cell (41,830), 5-8-cell (21,946), 9-14-cell (11,009), morula (4,538), and blastocyst stages (3,248).
OCR
No difference was found between oocyte and 8-cell stages in mtOCR (0.37-0.68 fmol/s; Fig. 3 ) nor in the max mtOCR (1.99-2.41 fmol/s). However, mtOCR and max mtOCR increased rapidly at 9-14-cell stage (P < 0.01; mtOCR = 1.34; max mtOCR = 3.19 fmol/s) compared with those until 8-cell stage. Furthermore, the mtOCR (5.13 fmol/s) and max mtOCR at blastocyst stage (6.81 fmol/s at the expanded blastocyst stage) were significantly higher than those until 14-cell stage (P < 0.01). OCRs increased toward the morula stage ahead of an increase of mtDNA at blastulation.
The mtOCR/mtDNA ratio increased toward blastocyst (P < 0.01, 1.55 × 10 ). Taken together, mtOCR per mtDNA rose along with the development of embryos until morula stage. 
CCO activity
The proportion of mitochondria with high CCO activity increased in blastocysts (P < 0.0001; 27.1%; 
Comparison of mitochondrial competence between day 4 embryos
Fifteen embryos on day 4 showed compaction (compacted morula), 11 embryos had 10 or more than 10 blastomeres, and 10 embryos had fewer than 10 blastomeres. There were no differences in the mtDNA copy number among the three stages of day 4 embryos (from 103,773 to 175,044 copies; Table 2 ). However, the mtOCR, maximum mtOCR, and mtOCR/mtDNA ratio of embryos with <10 blastomeres were significantly lower (P < 0.01) than those of compacted morulae.
Mitochondrial activity of ICM cells
mtOCR was measured at one point of the TE located near the ICM and at two points of the TE far from the ICM. The ICM was identified in all expanded blastocysts used in this study (N = 19). There was no difference in the mtOCR between the TE (5.3 fmol/s) and ICM sides 7 h after warming (5.2 fmol/s). In addition, the proportion of mitochondria with high CCO activity in ICM cells (6.1%) was lower than in TE cells (P < 0.01; 32.2%; Fig. 5c ). 
Discussion
Mitochondria in human oocytes and preimplantation embryos have minimum contents of matrix membranes and appear relatively inactive [30] [31] [32] . Here, we found that matrix membranes and mitochondrial functions developed in parallel with embryo growth while the mtDNA copy numbers decreased transiently. OCRs increased toward the morula stage ahead of an increase of mtDNA at the time of blastulation.
Although mtDNA copy numbers remained constant in preimplantation mouse embryos [7, 8] , they decreased transiently in those of cattle [9] and pigs [10, 11] . The latter study was consistent with the findings that the expressions of DNA polymerase γ (POLG) and TFAM at 2-, 8-, and 16-cell stages decreased in porcine embryos [10] . The expression levels of transcription and replication factors of mtDNA before the morula stage were extremely low, even though expressions of these genes can be detected during cleavage stages in several mammalian species, such as the sheep [33] and pig [10] . Taken together, the expressions of these genes in human embryos might be downregulated until the morula stage, similarly to those of other mammals. The level of mtDNA in human embryos might also be transiently decreased by mechanisms similar to those involved in the low expression of embryonic genes before their activation [34] . In addition, it has been shown that mtDNA was detected in culture media [35] . [15, 16] . However, Victor et al. revealed that there were no differences after mathematical correction in the number of mtDNA copy in blastocyst between aged (38-46 years old) and young mothers (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) , between euploid and aneuploidy, and between implanted and not implanted [17] . In this study, cause of infertility did not affect the number of mtDNA copy in 2-4-cell stage embryo in contrast to a previous report [13] . Moreover, we did not consider chromosome normality and further developmental competence after uterine transfer and used mature oocytes that were obtained after an additional culture of immature oocytes at the time of ICSI in accordance with guidelines of the Japan Society of Obstetrics and Gynecology and ethical reason. Time and further studies will tell whether mtDNA levels would be affected by stress state. The data was obtained from ICSI embryos and may not be indicative of what happens with IVF nor natural fertilization.
Estimates of the contribution of mitochondrial respiration to energetic requirements during embryonic development suggest that about 10% of glucose available is metabolized through aerobic respiration in the early stages of development, while it increases to 85% in the blastocyst stage [30] , with concomitant increases in OCR in mice [19, 20, 36] and cattle [18] . The present work shows that mtOCR, max mtOCR, and CCO activity in human preimplantation embryos increased along with their development while the mtDNA copy numbers decreased transiently, indicating the activation of mitochondrial metabolism. The mtOCR of well-developed embryos on day 4 was higher than that of delayed embryos with a concomitant increase in the mtOCR/mtDNA ratio, suggesting that the increase in OCR parallels the morphological changes in embryos and might serve as a marker for viable embryos after day 4 because the formation of blastocoel cavity depends on cellular Na/K-ATPase activity [23] . In addition, OCRs increased drastically from morula to blastocyst stage in accordance with previous data [22, 27] earlier than an increase of mtDNA at the time of blastulation.
There was no difference in the OCR between the ICM and TE sides of blastocysts, suggesting a low OCR in the ICM. Cells in the ICM retain a pluripotent status as shown by the expressions of Oct4, Tra-1-60, Tra-1-81, and alkaline phosphatase [37] , indicating a relatively dormant state with persistently low levels of POLG and TFAM [4] , and depending on anaerobic metabolism [38] . The TE cells contained elongated mitochondria with high CCO activity whereas the mitochondria in ICM cells were spherical with low CCO activity (Fig. 5) . Taken together, the undifferentiated state of ICM cells appears to be associated with low levels of expression of mtDNA transcription and replication factors. On the other hand, the mtDNA copy number increases and energy production shifts from anaerobic glycolysis to mitochondrial aerobic metabolism in TE cells during development.
Viable human blastocysts can be grown in defined culture systems in the absence of serum and somatic cells [39] . The development and use of sequential culture media, designed to cater for the changing requirements of embryos during their development and differentiation, have been shown to produce blastocysts with high viability [40] [41] [42] . Modifying the energy sources required for mitochondrial function should provide a less stressful environment for embryos. Thus, the present work showing changes in mitochondrial structure, function, and mtDNA copy numbers during preimplantation development will be useful in optimizing culture media for the development of human embryos. 
